Abstract

Introduction/BackgroundAchieving a status of no residual disease (CC 0) following cytoreductive surgery in advanced epithelial ovarian cancer (EOC) is crucial for favourable prognoses in affected women. The challenge lies in...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call